Editorial: Can Prostate Specific Antigen Derivatives Reduce the Frequency of Unnecessary Prostate Biopsies?

No AccessJournal of UrologyClinical Urology: Editorial1 Aug 1996Editorial: Can Prostate Specific Antigen Derivatives Reduce the Frequency of Unnecessary Prostate Biopsies? Eric A. Klein Eric A. KleinEric A. Klein More articles by this author View All Author Informationhttps://doi.org/10.1016/S0022-5347(01)65874-9AboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail "Editorial: Can Prostate Specific Antigen Derivatives Reduce the Frequency of Unnecessary Prostate Biopsies?." The Journal of Urology, 156(2), pp. 443–444 References 1 : A prospective evaluation of plasma prostate-specific antigen for detection of prostatic cancer. J.A.M.A.1995; 273: 289. Google Scholar 2 : The influence of prostate size on cancer detection. Urology1995; 46: 831. Google Scholar Section of Urologic Oncology, Department of Urology, Cleveland Clinic Foundation, Cleveland, Ohio.© 1996 by American Urological Association, Inc.FiguresReferencesRelatedDetailsCited byBozeman C, Carver B, Eastham J and Venable D (2018) Treatment Of Chronic Prostatitis Lowers Serum Prostate Specific AntigenJournal of Urology, VOL. 167, NO. 4, (1723-1726), Online publication date: 1-Apr-2002. Volume 156Issue 2August 1996Page: 443-444 Advertisement Copyright & Permissions© 1996 by American Urological Association, Inc.MetricsAuthor Information Eric A. Klein More articles by this author Expand All Advertisement PDF downloadLoading ...